Repository logo
 
Publication

Molecular characterisation of cutaneous melanoma

dc.contributor.authorNunes, I.
dc.contributor.authorCosta, C.
dc.contributor.authorMartin, C.
dc.contributor.authorAndrade, M. I.
dc.contributor.authorJoão, A.
dc.contributor.authorLopes, J. M.
dc.contributor.authorBarata, C.
dc.contributor.authorSoares, Paula
dc.contributor.authorPopulo, H.
dc.date.accessioned2023-12-09T18:32:44Z
dc.date.available2023-12-09T18:32:44Z
dc.date.issued2023-06
dc.description.abstractIntroduction: Cutaneous melanoma (CM) is the least frequent but deadliest kind of skin cancer, highlighting the aggressiveness of these tumors. As a result of prolonged exposure to UV radiation, CM harbors one of the highest mutation rates among all malignancies. The three most common mutations occur in BRAF and NRAS genes, both important for the mitogen-activated protein kinase pathway upregulation, and in the telomerase reverse transcriptase promoter, which is linked to a poor prognosis. Although current therapies have improved patients’ overall survival, low response rates and treatment resistance remain major challenges for melanoma treatment. Therefore, melanoma investigations have shifted their interest to microRNAs (miRNAs), like miR-125a, miR- 155, and miR- 579, noncoding RNAs that affect the hallmarks of cancer and are potential melanoma biomarkers. Project Aim: To study the molecular alterations of melanomas, to correlate them with the patients’ clinicopathological data and follow-up, and to identify possible prognostic and/or therapeutic biomarkers. Materials and Methods: The mutational status analysis was performed by the Sanger method in primary tumors, metastatic lymph nodes, and metastases collected at Hospital de Santarém and Hospital dos Capuchos. Whereas miRNA expression, from primary tumors collected at Hospital de Santarém, was analyzed by RT-PCR Results: The median age of the studied series was 65 years, where most.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationNunes I, Costa C, Martin C, Andrade MI, João A, Soares P, et al. Molecular characterisation of cutaneous melanoma. In: 57th Annual Scientific Meeting, Prague (Czech Republic), June 7-9, 2023. Eur J Clin Invest. 2023;53(Suppl 1):100-1.pt_PT
dc.identifier.doihttps://doi.org/10.1111/eci.13992pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.21/16657
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/toc/13652362/2023/53/S1pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectCutaneous melanomapt_PT
dc.subjectSkin cancerpt_PT
dc.subjectMolecular characterizationpt_PT
dc.titleMolecular characterisation of cutaneous melanomapt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.endPage101pt_PT
oaire.citation.issueSuppl 1pt_PT
oaire.citation.startPage100pt_PT
oaire.citation.titleEuropean Journal of Clinical Investigationpt_PT
oaire.citation.volume53pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Molecular characterisation of cutaneous melanoma.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections